HEADER STRUCTURAL PROTEIN 19-OCT-23 8WTV TITLE CRYO-EM STRUCTURE OF NORADRENALINE TRANSPORTER IN COMPLEX WITH TITLE 2 NORADRENALINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SODIUM-DEPENDENT NORADRENALINE TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC6A2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS PROTEIN STRUCTURE, STRUCTURAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR Y.ZHAO,T.HU,Z.YU REVDAT 3 04-SEP-24 8WTV 1 JRNL REVDAT 2 14-AUG-24 8WTV 1 JRNL REVDAT 1 07-AUG-24 8WTV 0 JRNL AUTH T.HU,Z.YU,J.ZHAO,Y.MENG,K.SALOMON,Q.BAI,Y.WEI,J.ZHANG,S.XU, JRNL AUTH 2 Q.DAI,R.YU,B.YANG,C.J.LOLAND,Y.ZHAO JRNL TITL TRANSPORT AND INHIBITION MECHANISMS OF THE HUMAN JRNL TITL 2 NORADRENALINE TRANSPORTER. JRNL REF NATURE V. 632 930 2024 JRNL REFN ESSN 1476-4687 JRNL PMID 39085602 JRNL DOI 10.1038/S41586-024-07638-Z REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.700 REMARK 3 NUMBER OF PARTICLES : 361801 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8WTV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1300041984. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : STRUCTURE OF A PROTEIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1000.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 52 REMARK 465 ALA A 53 REMARK 465 GLN A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLU A 57 REMARK 465 THR A 58 REMARK 465 TRP A 59 REMARK 465 GLY A 60 REMARK 465 LYS A 61 REMARK 465 LYS A 62 REMARK 465 ILE A 63 REMARK 465 ASP A 64 REMARK 465 PHE A 65 REMARK 465 LEU A 66 REMARK 465 LEU A 67 REMARK 465 LYS A 189 REMARK 465 LEU A 190 REMARK 465 LEU A 191 REMARK 465 ASN A 192 REMARK 465 GLY A 193 REMARK 465 SER A 194 REMARK 465 VAL A 195 REMARK 465 LEU A 196 REMARK 465 GLY A 197 REMARK 465 ASN A 198 REMARK 465 HIS A 199 REMARK 465 THR A 200 REMARK 465 LYS A 201 REMARK 465 TYR A 202 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 131 89.34 -155.10 REMARK 500 THR A 258 41.24 -102.36 REMARK 500 SER A 259 66.97 60.49 REMARK 500 THR A 268 -53.84 -120.46 REMARK 500 LYS A 303 -2.35 67.28 REMARK 500 ASN A 539 40.94 -107.71 REMARK 500 ASP A 546 -101.54 55.50 REMARK 500 ARG A 604 60.44 60.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-37843 RELATED DB: EMDB REMARK 900 STRUCTURE OF A PROTEIN DBREF 8WTV A 52 617 UNP P23975 SC6A2_HUMAN 52 617 SEQRES 1 A 566 ASP ALA GLN PRO ARG GLU THR TRP GLY LYS LYS ILE ASP SEQRES 2 A 566 PHE LEU LEU SER VAL VAL GLY PHE ALA VAL ASP LEU ALA SEQRES 3 A 566 ASN VAL TRP ARG PHE PRO TYR LEU CYS TYR LYS ASN GLY SEQRES 4 A 566 GLY GLY ALA PHE LEU ILE PRO TYR THR LEU PHE LEU ILE SEQRES 5 A 566 ILE ALA GLY MET PRO LEU PHE TYR MET GLU LEU ALA LEU SEQRES 6 A 566 GLY GLN TYR ASN ARG GLU GLY ALA ALA THR VAL TRP LYS SEQRES 7 A 566 ILE CYS PRO PHE PHE LYS GLY VAL GLY TYR ALA VAL ILE SEQRES 8 A 566 LEU ILE ALA LEU TYR VAL GLY PHE TYR TYR ASN VAL ILE SEQRES 9 A 566 ILE ALA TRP SER LEU TYR TYR LEU PHE SER SER PHE THR SEQRES 10 A 566 LEU ASN LEU PRO TRP THR ASP CYS GLY HIS THR TRP ASN SEQRES 11 A 566 SER PRO ASN CYS THR ASP PRO LYS LEU LEU ASN GLY SER SEQRES 12 A 566 VAL LEU GLY ASN HIS THR LYS TYR SER LYS TYR LYS PHE SEQRES 13 A 566 THR PRO ALA ALA GLU PHE TYR GLU ARG GLY VAL LEU HIS SEQRES 14 A 566 LEU HIS GLU SER SER GLY ILE HIS ASP ILE GLY LEU PRO SEQRES 15 A 566 GLN TRP GLN LEU LEU LEU CYS LEU MET VAL VAL VAL ILE SEQRES 16 A 566 VAL LEU TYR PHE SER LEU TRP LYS GLY VAL LYS THR SER SEQRES 17 A 566 GLY LYS VAL VAL TRP ILE THR ALA THR LEU PRO TYR PHE SEQRES 18 A 566 VAL LEU PHE VAL LEU LEU VAL HIS GLY VAL THR LEU PRO SEQRES 19 A 566 GLY ALA SER ASN GLY ILE ASN ALA TYR LEU HIS ILE ASP SEQRES 20 A 566 PHE TYR ARG LEU LYS GLU ALA THR VAL TRP ILE ASP ALA SEQRES 21 A 566 ALA THR GLN ILE PHE PHE SER LEU GLY ALA GLY PHE GLY SEQRES 22 A 566 VAL LEU ILE ALA PHE ALA SER TYR ASN LYS PHE ASP ASN SEQRES 23 A 566 ASN CYS TYR ARG ASP ALA LEU LEU THR SER SER ILE ASN SEQRES 24 A 566 CYS ILE THR SER PHE VAL SER GLY PHE ALA ILE PHE SER SEQRES 25 A 566 ILE LEU GLY TYR MET ALA HIS GLU HIS LYS VAL ASN ILE SEQRES 26 A 566 GLU ASP VAL ALA THR GLU GLY ALA GLY LEU VAL PHE ILE SEQRES 27 A 566 LEU TYR PRO GLU ALA ILE SER THR LEU SER GLY SER THR SEQRES 28 A 566 PHE TRP ALA VAL VAL PHE PHE VAL MET LEU LEU ALA LEU SEQRES 29 A 566 GLY LEU ASP SER SER MET GLY GLY MET GLU ALA VAL ILE SEQRES 30 A 566 THR GLY LEU ALA ASP ASP PHE GLN VAL LEU LYS ARG HIS SEQRES 31 A 566 ARG LYS LEU PHE THR PHE GLY VAL THR PHE SER THR PHE SEQRES 32 A 566 LEU LEU ALA LEU PHE CYS ILE THR LYS GLY GLY ILE TYR SEQRES 33 A 566 VAL LEU THR LEU LEU ASP THR PHE ALA ALA GLY THR SER SEQRES 34 A 566 ILE LEU PHE ALA VAL LEU MET GLU ALA ILE GLY VAL SER SEQRES 35 A 566 TRP PHE TYR GLY VAL ASP ARG PHE SER ASN ASP ILE GLN SEQRES 36 A 566 GLN MET MET GLY PHE ARG PRO GLY LEU TYR TRP ARG LEU SEQRES 37 A 566 CYS TRP LYS PHE VAL SER PRO ALA PHE LEU LEU PHE VAL SEQRES 38 A 566 VAL VAL VAL SER ILE ILE ASN PHE LYS PRO LEU THR TYR SEQRES 39 A 566 ASP ASP TYR ILE PHE PRO PRO TRP ALA ASN TRP VAL GLY SEQRES 40 A 566 TRP GLY ILE ALA LEU SER SER MET VAL LEU VAL PRO ILE SEQRES 41 A 566 TYR VAL ILE TYR LYS PHE LEU SER THR GLN GLY SER LEU SEQRES 42 A 566 TRP GLU ARG LEU ALA TYR GLY ILE THR PRO GLU ASN GLU SEQRES 43 A 566 HIS HIS LEU VAL ALA GLN ARG ASP ILE ARG GLN PHE GLN SEQRES 44 A 566 LEU GLN HIS TRP LEU ALA ILE HET NA A 701 1 HET NA A 702 1 HET CL A 703 1 HET E5E A 704 12 HET E5E A 705 12 HET NAG A 706 14 HETNAM NA SODIUM ION HETNAM CL CHLORIDE ION HETNAM E5E NORADRENALINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NA 2(NA 1+) FORMUL 4 CL CL 1- FORMUL 5 E5E 2(C8 H12 N O3 1+) FORMUL 7 NAG C8 H15 N O6 FORMUL 8 HOH *3(H2 O) HELIX 1 AA1 LEU A 76 ASN A 89 1 14 HELIX 2 AA2 GLY A 91 ALA A 93 5 3 HELIX 3 AA3 PHE A 94 ALA A 105 1 12 HELIX 4 AA4 ALA A 105 ARG A 121 1 17 HELIX 5 AA5 ALA A 125 PHE A 134 5 10 HELIX 6 AA6 LYS A 135 SER A 166 1 32 HELIX 7 AA7 THR A 208 GLY A 217 1 10 HELIX 8 AA8 HIS A 220 SER A 224 5 5 HELIX 9 AA9 GLN A 234 SER A 251 1 18 HELIX 10 AB1 LYS A 261 ALA A 267 1 7 HELIX 11 AB2 THR A 268 THR A 283 1 16 HELIX 12 AB3 GLY A 286 LEU A 295 1 10 HELIX 13 AB4 GLU A 304 GLY A 320 1 17 HELIX 14 AB5 GLY A 324 SER A 331 1 8 HELIX 15 AB6 ASN A 338 LYS A 373 1 36 HELIX 16 AB7 LEU A 386 SER A 396 1 11 HELIX 17 AB8 GLY A 400 PHE A 435 1 36 HELIX 18 AB9 GLN A 436 ARG A 440 5 5 HELIX 19 AC1 HIS A 441 LEU A 458 1 18 HELIX 20 AC2 PHE A 459 THR A 462 5 4 HELIX 21 AC3 GLY A 464 ALA A 476 1 13 HELIX 22 AC4 GLY A 478 PHE A 495 1 18 HELIX 23 AC5 GLY A 497 GLY A 510 1 14 HELIX 24 AC6 GLY A 514 PHE A 523 1 10 HELIX 25 AC7 PHE A 523 ASN A 539 1 17 HELIX 26 AC8 PRO A 551 VAL A 567 1 17 HELIX 27 AC9 VAL A 567 SER A 579 1 13 HELIX 28 AD1 SER A 583 THR A 593 1 11 HELIX 29 AD2 PRO A 594 HIS A 598 5 5 HELIX 30 AD3 HIS A 599 ARG A 604 1 6 HELIX 31 AD4 ILE A 606 PHE A 609 5 4 HELIX 32 AD5 GLN A 610 ALA A 616 1 7 SHEET 1 AA1 2 THR A 544 TYR A 545 0 SHEET 2 AA1 2 TYR A 548 ILE A 549 -1 O TYR A 548 N TYR A 545 SSBOND 1 CYS A 176 CYS A 185 1555 1555 2.02 LINK ND2 ASN A 184 C1 NAG A 706 1555 1555 1.43 LINK O VAL A 74 NA NA A 702 1555 1555 2.82 LINK OD1 ASN A 350 NA NA A 701 1555 1555 2.30 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000